nach oben

Erschienen in:

01.12.2012 | Article

A two-step screening algorithm including fasting plasma glucose measurement and a risk estimation model is an accurate strategy for detecting gestational diabetes mellitus

verfasst von: C. S. Göbl, L. Bozkurt, P. Rivic, G. Schernthaner, R. Weitgasser, G. Pacini, M. Mittlböck, D. Bancher-Todesca, M. Lechleitner, A. Kautzky-Willer

Erschienen in: Diabetologia | Ausgabe 12/2012

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

It is currently not clear how to construct a time- and cost-effective screening strategy for gestational diabetes mellitus (GDM). Thus, we elaborated a simple screening algorithm combining (1) fasting plasma glucose (FPG) measurement; and (2) a multivariable risk estimation model focused on individuals with normal FPG levels to decide if a further OGTT is indicated.

Methods

A total of 1,336 women were prospectively screened for several risk factors for GDM within a multicentre study conducted in Austria. Of 714 women (53.4%) who developed GDM using recent diagnostic guidelines, 461 were sufficiently screened with FPG. A risk prediction score was finally developed using data from the remaining 253 women with GDM and 622 healthy women. The screening algorithm was validated with a further 258 pregnant women.

Results

A risk estimation model including history of GDM, glycosuria, family history of diabetes, age, preconception dyslipidaemia and ethnic origin, in addition to FPG, was accurate for detecting GDM in participants with normal FPG. Including an FPG pretest, the receiver operating characteristic AUC of the screening algorithm was 0.90 (95% CI 0.88, 0.91). A cut-off value of 0.20 was able to differentiate between low and intermediate risk for GDM with a high sensitivity. Comparable results were seen with the validation cohort. Moreover, we demonstrated an independent association between values derived from the risk estimation and macrosomia in offspring (OR 3.03, 95% CI 1.79, 5.19, p < 0.001).

Conclusions/interpretation

This study demonstrates a new concept for accurate but cheap GDM screening. This approach should be further evaluated in different populations to ensure an optimised diagnostic algorithm.

Nur mit Berechtigung zugänglich

Pedersen J (1967) The pregnant diabetic and her newborn: problems and management. William & Wilkins, Baltimore, pp 128–137

Pettitt DJ, Knowler WC, Bennett PH, Aleck KA, Baird HR (1987) Obesity in offspring of diabetic Pima Indian women despite normal birth weight. Diabetes Care 10:76–80PubMedCrossRef

Catalano PM, Hauguel-De Mouzon S (2011) Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol 204:479–487PubMedCrossRef

Metzger BE, Coustan DR (1998) Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 21(Suppl 2):B161–B167PubMed

Kjos SL, Buchanan TA (1999) Gestational diabetes mellitus. N Engl J Med 341:1749–1756PubMedCrossRef

Kim C, Newton KM, Knopp RH (2002) Gestational diabetes and the incidence of type 2 diabetes. Diabetes Care 25:1862–1868PubMedCrossRef

Bozkurt L, Göbl CS, Tura A et al (2012) Fatty liver index predicts further metabolic deteriorations in women with previous gestational diabetes. PLoS One 7:e32710PubMedCrossRef

Retnakaran R (2009) Glucose tolerance status in pregnancy: a window to the future risk of diabetes and cardiovascular disease in young women. Curr Diabetes Rev 5:239–244PubMedCrossRef

Bellamy L, Casas JP, Hingorani AD, Williams D (2009) Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta analysis. Lancet 373:1773–1779PubMedCrossRef

10.

Göbl CS, Bozkurt L, Prikoszovich T, Winzer C, Pacini G, Kautzky-Willer A (2011) Early possible risk factors for overt diabetes after gestational diabetes mellitus. Obstet Gynecol 118:71–78PubMedCrossRef

11.

Farrar D, Duley L, Lawlor DA (2011) Different strategies for diagnosing gestational diabetes to improve maternal and infant health. Cochrane Database Syst Rev, Issue 10, Art. no. CD007122

12.

Tieu J, Middleton P, McPhe AJ, Crowther CA (2011) Screening and subsequent management for gestational diabetes for improving maternal and infant health. Cochrane Database Syst Rev, Issue 7, Art. no. CD007222

13.

Metzger BE, Buchanan TA, Coustan DR et al (2007) Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 30:251–260CrossRef

14.

Kautzky-Willer A, Bancher-Todesca D, Weitgasser R et al (2008) The impact of risk factors and more stringent diagnostic criteria of gestational diabetes on outcomes in central European women. J Clin Endocrinol Metab 93:1689–1695PubMedCrossRef

15.

Griffin ME, Coffey M, Johnson H et al (2000) Universal vs. risk factor-based screening for gestational diabetes mellitus: detection rates, gestation at diagnosis and outcome. Diabet Med 17:26–32PubMedCrossRef

16.

van Leeuwen M, Opmer BC, Zweers EJ et al (2010) Estimating the risk of gestational diabetes mellitus: a clinical prediction model based on patient characteristics and medical history. BJOG 117:69–75PubMedCrossRef

17.

Naylor CD, Sermer M, Chen E, Farine D (1997) Selective screening for gestational diabetes mellitus. N Engl J Med 337:1591–1596PubMedCrossRef

18.

Phaloprakarn C, Tangjitgamol S, Manusirivithaya S (2009) A risk score for selective screening for gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol 145:71–75PubMedCrossRef

19.

Agarwal MM, Dhatt GS, Shah SM (2010) Gestational diabetes mellitus: simplifying the international association of diabetes and pregnancy diagnostic algorithm using fasting plasma glucose. Diabetes Care 33:2018–2020PubMedCrossRef

20.

International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycaemia in pregnancy. Diabetes Care 33:676–682CrossRef

21.

Goeman J (2010) L1 and L2 penalized regression models. Available from: http://cran.r-project.org/web/packages/penalized/vignettes/penalized.pdf. Accessed 19 November 2011

22.

Goeman JJ (2010) L1 penalized estimation in the Cox proportional hazards model. Biom J 52:70–84PubMed

23.

R Development Core Team (2011) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available from: www.R-project.org. Accessed 19 November 2011

24.

Caliskan E, Kayikcioglu F, Öztürk N, Koc S, Haberal A (2004) A population-based risk factor scoring will decrease unnecessary testing for the diagnosis of gestational diabetes mellitus. Acta Obstet Gynecol Scand 83:524–530PubMed

25.

Coustan DR, Lowe LP, Metzger BE, Dyer AR (2010) The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: paving the way for new diagnostic criteria for gestational diabetes mellitus. Am J Obstet Gynecol 202:654.e.1–6CrossRef

26.

Riskin-Mashiah S, Damti A, Auslender R (2010) First trimester fasting hyperglycemia as a predictor for the development of gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol 152:163–167PubMedCrossRef

27.

Siegmund T, Rad NT, Ritterath C, Siebert G, Heinrich W, Buhling KJ (2008) Longitudinal changes in the continous glucose profile measured by the CGMS in healthy pregnant women and determination of cut-off values. Eur J Obstet Gynecol Reprod Biol 139:46–51PubMedCrossRef

28.

Black MH, Sacks DA, Xiang AH, Lawrence JM (2010) Clinical outcomes of pregnancies complicated by mild gestational diabetes differ by combinations of abnormal oral glucose tolerance test values. Diabetes Care 33:2524–2530PubMedCrossRef

29.

Boerschmann H, Pflüger M, Henneberger L, Ziegler AG, Hummel S (2010) Prevalence and predictors of overweight and insulin resistence in offspring of mothers with gestational diabetes mellitus. Diabetes Care 33:1845–1849PubMedCrossRef

30.

Schaefer-Graf UM, Graf K, Kulbacka I et al (2008) Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care 31:1858–1863PubMedCrossRef

31.

Göbl CS, Handisurya A, Klein K et al (2010) Changes in serum lipid levels during pregnancy in type 1 and type 2 diabetic subjects. Diabetes Care 33(9):2071–2073PubMedCrossRef

32.

Scott DA, Loveman E, McIntyre L, Waugh N (2002) Screening for gestational diabetes: a systematic review and economic evaluation. Health Technol Assess 6:1–161PubMed

33.

Kjos S, Buchanan T, Langer O, Yariv Y, Most O, Xenakis EM (2005) Gestational diabetes: the consequence of not treating. Am J Obstet Gynecol 192:989–997CrossRef

34.

Savvidou M, Nelson SM, Makgoba M, Messow CM, Sattar N, Nicolaides K (2010) First-trimester prediction of gestational diabetes mellitus: examining the potential of combining maternal characteristics and laboratory measures. Diabetes 59:3017–3022PubMedCrossRef

35.

Kjos SL, Schaefer-Graf UM (2007) Modified therapy for gestational diabetes using high-risk and low-risk fetal abdominal circumference growth to select strict versus relaxed maternal glycaemic targets. Diabetes Care 30:S200–S205PubMedCrossRef

36.

Meltzer SJ, Snyder J, Penrod JR, Nudi M, Morin L (2010) Gestational diabetes mellitus screening and diagnosis: a prospective randomised controlled trial comparing costs of one-step and two-step methods. BJOG 117:407–415PubMedCrossRef

37.

Werner EF, Pettker CM, Zuckerwise L et al (2012) Screening for gestational diabetes mellitus: are the criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups cost effective? Diabetes Care 35:529–535PubMedCrossRef

38.

Sacks DA, Haden DR, Maresch M, HAPO Study Cooperative Research Group et al (2012) Frequency of Gestational Diabetes Mellitus at collaborating centers based on IADPSG Consensus Panel recommend criteria. Diabetes Care 35:526–528PubMedCrossRef

Titel: A two-step screening algorithm including fasting plasma glucose measurement and a risk estimation model is an accurate strategy for detecting gestational diabetes mellitus
verfasst von: C. S. Göbl
L. Bozkurt
P. Rivic
G. Schernthaner
R. Weitgasser
G. Pacini
M. Mittlböck
D. Bancher-Todesca
M. Lechleitner
A. Kautzky-Willer
Publikationsdatum: 01.12.2012
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 12/2012
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-012-2726-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

A two-step screening algorithm including fasting plasma glucose measurement and a risk estimation model is an accurate strategy for detecting gestational diabetes mellitus

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2012

Implementation of the automated Leicester Practice Risk Score in two diabetes prevention trials provides a high yield of people with abnormal glucose tolerance

Enterovirus-induced gene expression profile is critical for human pancreatic islet destruction

Depletion of homeodomain-interacting protein kinase 3 impairs insulin secretion and glucose tolerance in mice

Development of a new scoring system for predicting the 5 year incidence of type 2 diabetes in Japan: the Toranomon Hospital Health Management Center Study 6 (TOPICS 6)

Multilevel examination of diabetes in modernising China: what elements of urbanisation are most associated with diabetes?

The role of Raf-1 kinase inhibitor protein in the regulation of pancreatic beta cell proliferation in mice

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin